The device is meant to treat atrial fibrillation patients who are unable to tolerate blood thinners to reduce stroke risk. It works by sealing the left atrial appendage — a small pouch connected to the heart’s upper left chamber — to prevent clots from forming in the area, the system said in a March 28 news release sent to Becker’s.
“The treatment option opens the door for many more patients who cannot be on blood thinners for even a short period. It also allows the LAA closure for different shapes and sizes,” said Ruby Satpathy, MD, an interventional cardiologist who implanted the device in a 75-year-old patient.
Leave a Reply